1 / 26

Bladder Paraganglioma: Experiences in National Taiwan University Hospital

Bladder Paraganglioma: Experiences in National Taiwan University Hospital. Yi-Kai Chang , Chao-Yaun Huang, Yeong-Shiau Pu, Chung-Hsin Chen, Shuo-Meng Wang, Yuan-Ju Lee, Huai-Ching Tai, Hong-Jeng Yu

haamid
Download Presentation

Bladder Paraganglioma: Experiences in National Taiwan University Hospital

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Bladder Paraganglioma: Experiences in National Taiwan University Hospital Yi-Kai Chang, Chao-Yaun Huang, Yeong-Shiau Pu, Chung-Hsin Chen, Shuo-Meng Wang,Yuan-Ju Lee, Huai-Ching Tai, Hong-Jeng Yu Department of Urology, National Taiwan University Hospital, College of Medicine, National Taiwan University

  2. Introduction • Pheochromocytomas are catecholamine-secreting tumors, derived from the adrenal gland and sympathetic nervous system. • Extra-adrenal pheochromocytomas, known as paragangliomas, account for about 15 % of all pheochromocytomas. • Extremely rare less than 0.06% of all bladder tumors , < 1% of all pheochromocytomas • Micturition attack

  3. Introduction • Definition of malignant paraganglioma Benign in nature but some cases with malignant behavior • No Definite pathology criteria for malignancy  local invasion  distant metastasis

  4. Materirals and Methods • We retrospectively searched the pathological and clinical database of National Taiwan University Hospital with ICD-9 and diagnosis in recent 15 years. • 6 cases of bladder paraganglioma were collected.

  5. Results Results • Case 1 • 21 y/o male • TUR-BT  paraganglioma • CT: 5.5*5.6 cm bladder tumor • Partial cystectomy in 2001 0828 • Pathology: malignant paraganglioma with perivesical fat invasion • Cystoscopy and abdominal and pelvic MRI followup 122 months so far and still alive

  6. Results Case 2 • 53 y/o female • Bladder blood clot tamponade • CT: huge bladder tumor with uterus/ vaginal invasion • Partial cystectomy, ATH+BSO • Patholgy: bladder malignant paraganglioma with uterus, bil ovary and vaginal invasion • V-V fistula was noted 3 months after operation • Died 21 months postoperatively of severe sepsis

  7. Results • Case 6 • 68 y/o male, BPH with LUTS • TUR-P+ TUR-BT 2011 04 • Pathology Bladder paraganglioma • CT: 6 mm enhanced lateral wall tumor • TUR-BT 201208, • Pathology: bladder paraganglioma

  8. Table 1 Clinical characteristics of 6 patients with bladder paraganglioma

  9. Table 2 tumor characteristics, surgical procedures and pathology data

  10. Results • The specimens of two malignant bladder paragangliomas were largepolypoid tumors, both rich in blood supply and were broad based tumors. • The specimens of other four benign paragangliomas were all smallround or ovoid tumors

  11. Discussion • Doctor Dana[1]reported 236 extra-adrenal benign paragangliomas, only 2 were bladder origins, 1 prostate paraganglioma • Our data A trend of female predominance [1]Erickson D, Benign paragangliomasJ Clin Endocrinol Metab. 2001 Nov;86(11):5210-6. [2]Leestma JE, Price EB: Paraganglioma of the urinary bladder. Cancer 1971; 28:1063-1073 [3]Paraganglioma of the urinary bladder first presented by bladder bloody tamponade: two case reports and review of the literatures. Tsai CC, Kaohsiung J Med Sci. 2011 Mar;27(3):108-13. Epub 2011 Feb 16.

  12. Discussion [2]Leestma JE, Price EB: Paraganglioma of the urinary bladder. Cancer 1971; 28:1063-1073 [3]Paraganglioma of the urinary bladder first presented by bladder bloody tamponade: two case reports and review of the literatures. Tsai CC, Kaohsiung J Med Sci. 2011 Mar;27(3):108-13. Epub 2011 Feb 16.

  13. Factors Suggesting Malignancy [4]Chin J Cancer. 2010 Aug;29(8):729-34. Functional paragangliomas of the urinary bladder: a report of 9 cases. Deng JH

  14. Surgical Intervention and Outcome in Taiwan

  15. TUR or partial cystectomy Defects in TUR: • Involve the muscularis propria of the bladder wall • Easy to recur if the tumor cannot be resected completely • Higher malignancy rate than pheochromocytoma [5]Diagnosis and treatment of pheochromocytoma in urinary bladder LIU Yong, J Zhejiang Univ Sci B. 2007 June; 8(6): 435–438

  16. Discussion • Post operative follow-up protocol should include annual cystoscopy, plasma or urine catecholamine analysis and an 131I-MIBGscan. • Annual biochemical testing [6] • Life-long follow-up is necessary to detect late recurrences as previous studies suggested. [6]Young WF. Paragangliomas: clinical overview. Ann N Y Acad Sci 2006;1073:21e9

  17. Conclusion • Female predominant • Painless gross hematuria  most common presenting symptom • Large, multiple, polypoid tumors  malignant • For small-sized lesion, TUR-BT but regular followup (image, biochemical testing, cystoscopy ) • For large-sized lesion, partial / radical cystectomy • Life long followup

  18. Thanks for your attention

  19. Pre-OP prophylaxis? • adrenergic blockade should be started at least 7 days preoperatively to allow for expansion of the contracted blood volume Young WF. Paragangliomas: clinical overview. Ann N Y Acad Sci 2006;1073:21e9.

  20. Post OP followup? • 1–2 weeks after surgery, 24-h urinary fractionated catecholamines and metanephrines • If the levels are normal, the resection of the biochemically active paraganglioma should be considered complete • Annual biochemical testing metastasis, recurrence [6]Young WF. Paragangliomas: clinical overview. Ann N Y Acad Sci 2006;1073:21e9.

  21. Table 4 Tumor Characteristics and Malignant Potential 謝佳秀

  22. Surgical intervention in China

  23. Table 3 Gender and Bladder Paraganglioma

  24. Table5 Surgical Intervention and Outcome in Taiwan

More Related